Yahoo
Paris - Delayed Quote EUR

Amoéba S.A. (ALMIB.PA)

0.2560 -0.0095 (-3.58%)
At close: 5:35:00 PM GMT+1
Chart Range Bar
Loading chart for ALMIB.PA
  • Previous Close 0.2655
  • Open 0.2700
  • Bid --
  • Ask --
  • Day's Range 0.2475 - 0.2700
  • 52 Week Range 0.2475 - 1.1200
  • Volume 615,644
  • Avg. Volume 663,881
  • Market Cap (intraday) 33.061M
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1400
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 1.00

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is headquartered in Chassieu, France.

amoeba-nature.com

23

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

ALMIB.PA
75.80%
CAC 40 (^FCHI)
2.21%

1-Year Return

ALMIB.PA
76.03%
CAC 40 (^FCHI)
2.30%

3-Year Return

ALMIB.PA
37.25%
CAC 40 (^FCHI)
16.77%

5-Year Return

ALMIB.PA
83.89%
CAC 40 (^FCHI)
16.68%

Analyst Insights

View More

Analyst Price Targets

1.00
1.00 Average
0.2560 Current
1.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    758.45k

  • Net Income Avi to Common (ttm)

    -11.8M

  • Diluted EPS (ttm)

    -0.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: